EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 23 January 2020

New IMI calls are now published!

IMI - Call 20

This week, the Innovative Medicines Initiative (IMI) has launched a new Call for proposals with funding opportunities in cancer, tuberculosis, vaccines, psoriatic arthritis and drugs based on proteins.

IMI will contribute EUR 133 million to the projects funded under the Call; these funds come from Horizon 2020 and will support the participation in the projects of organisations such as universities, small and medium-sized enterprises, and patient groups. EFPIA companies and IMI Associated Partners will contribute EUR 140 million, mostly as ‘in kind’ contributions (e.g. staff time, access to equipment, etc.). Read more

EFPIA statement on CJEU ruling on clinical trial transparency

EFPIA statement on CJEU ruling on clinical trial transparency
22 January 2020

EFPIA notes the decision by the Court of Justice of the European Union (CJEU) in the case of PTC Therapeutics International... Read more

Cancer care in Europe: Where are we in 2020?

The Comparator Report on Cancer in Europe provides an overview of the current state of cancer care in Europe. Developed by the Swedish Institute for Health Economics, it reflects on major trends in cancer across Europe, including patient outcomes, disease burden and patient access to care and treatment as well as potential solutions to tackle cancer.

To find out more about the report, join us on 29 January 2020, from 14:30 to 16:30 at the Renaissance Hotel Brussels (Rue du Parnasse 19, 1050 Brussels) for the official launch.

Events

Cancer care in Europe: Where are we in 2020?
29 January 2020 (Brussels, Belgium)

Discussion on the key findings of the Comparator Report on Cancer in Europe Read more

Towards outcomes-based healthcare in Europe
04 February 2020 (Brussels)

The EU Health Coalition seeks to explore how the State of Health in the EU can help address current health systems challenges... Read more

Joint MEB/DIA Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing
15 June 2020 (Virtual Live Training Course)

Join this training to discover the latest news on the international harmonisation and standardisation activities in... Read more

Vaccines Europe calls to boost collaboration on seasonal influenza

At an event held in the European Parliament this week, policymakers noted the lack of progress made by EU Member States towards the EU’s 75% target for seasonal influenza vaccination coverage rates among older-age and at-risk groups, first adopted in the EU Council Recommendation on seasonal influenza vaccination in 2009. (Read more)

What we are reading

The story of one frustrated scientist’s mission to beat flu
On 17 January 2020 (Vaccines Today)

After four decades working on influenza, this vaccines expert decided to embrace a new way to tell the flu vaccine story... Read more

Faces | The person behind the science
On 21 January 2020 (Innodia)

Innodia joins academic researchers, industry and patients to fight Type 1 Diabetes. Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu